Loading stock data…
$18.50+0.00 (+0.00%)
Simulations Plus, Inc.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $21.89M↓ | $24.29M↑ | $18.42M↑ | $17.46M↓ | $20.36M |
| Gross Profit | $15.13M↓ | $16.14M↑ | $10.89M↑ | $9.84M↓ | $13.03M |
| Operating Income | $4.50M↓ | $5.63M↑ | $713,000↑ | $659,000↓ | $3.00M |
| Net Income | $3.58M↓ | $4.54M↑ | $676,000↑ | -$681,000↑ | -$67.32M |
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Softwar...